Pulse Biosciences Inc 2025年度报告

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act.Yes☐No☒ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file suchreports), and (2) has been subject to such filing requirements for the past 90 days. Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period thatthe registrant was required to submit such files).Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smallerreporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smallerreporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act: If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of theeffectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) bythe registered public accounting firm that prepared or issued its audit report.☐ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of theregistrant included in the filing reflect the correction of an error to previously issued financial statements.☐ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-basedcompensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b).☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).Yes☐No☒ Aggregate market value of registrant’s common stock held by non-affiliates of the registrant on March 31, 2026, the last businessday of the registrant’s most recently completed first fiscal quarter, based upon the closing price of the registrant’s common stock onsuch date as reported by Nasdaq Capital Market, was approximately $394,339,817. Shares of voting stock held by each officer anddirector have been excluded in that such persons may be deemed to be affiliates. This assumption regarding affiliate status is notnecessarily a conclusive determination for other purposes. Number of shares outstanding of the registrant’s common stock as ofMarch 31, 2026: 68,225,067 Auditor NameAuditor LocationAuditor Firm IDDeloitte & Touche LLPSan Francisco, CaliforniaPCAOB ID 34 DOCUMENTS INCORPORATED BY REFERENCE: EXPLANATORY NOTE The Company is filing this Amendment No. 1 (“Amendment”) to its Annual Report on Form 10‑K for the fiscal year endedDecember 31, 2025, originally filed with the Securities and Exchange Commission (the “SEC”) on February 19, 2026 (the“Original Filing”), for the purpose of providing the information required by Items 10, 11, 12, 13, and 14 of Part III of Form 10-K.This information was previously omitted from the Original Filing in reliance on General Instruction G(3) to the Annual Report onForm 10-K, which permits the above-referenced Items to be incorporated in the Annual Report on Form 10-K by reference from adefinitive proxy statement, if such definitive proxy statement is filed no later than 120 days after December 31, 2025. Pursuant to the rules of the SEC, we have also included as exhibits currently dated certifications required under Section 302of The Sarbanes-Oxley Act of 2002. Because no financial statements are contained within this Amendment, we are not includingcertifications pursuant to Section 906 of The Sarbanes-Oxley Act of 2002. We are amending and refiling Part IV to reflect theinclusion of those certifications, along with any changes to Part IV that occurred after the date of the Original Filing. In addition, we made certain revisions to the cover page, including the deletion of the reference to our proxy statement. Except as described above, no other changes have been made to the Original Filing. Except as otherwise indicated herein,this Amendment continues to speak as of the date of the Original Filing, and the Company has not updated the disclosurescontained therein to reflect any events that occurred subsequent to the date of the Original Filing. SPECIAL NOTE ABOUT FORWARD-LOOKING STATEMENTS This Amendment contains certain “forward-looking statements” that inv